Brain-derived neurotrophic factor (BDNF) has been reported to exert an acute potentiation of synaptic activity. Here we examined the action of BDNF on synchronous spontaneous Ca 2؉ oscillations in cultured cerebral cortical neurons prepared from postnatal 2-3-dayold rats. The synchronous spontaneous Ca 2؉ oscillations beganatapproximatelyDIV5.Itwasrevealedthatvoltagedependent Ca 2؉ channels and ionotropic glutamate receptors were involved in the synchronous spontaneous oscillatory activity. BDNF potentiated the frequency of these oscillations. The BDNF-potentiated activity reached 207 ؎ 20.1% of basal oscillatory activity. NT-3 and NT-4/5 also induced the potentiation. However, nerve growth factor did not. We examined the correlation between BDNF-induced glutamate release and the BDNF-potentiated oscillatory activity. Both up-regulation of phospholipase C-␥ (PLC-␥) expression and the BDNF-induced glutamate release occurred at approximately DIV 5 when the BDNF-potentiated oscillations appeared. We confirmed that the BDNF-induced glutamate release occurred through a glutamate transporter that was dependent on the PLC-␥/IP 3 /Ca 2؉ pathway. Transporter inhibitors blocked the BDNF-potentiated oscillations, demonstrating that BDNF enhanced the glutamatergic transmissions in the developing cortical network by inducing glutamate release via a glutamate transporter.
Neurotrophins play important roles in the survival and differentiation of the peripheral nervous system and CNS 1 neurons. Besides having long term effects, neurotrophins play a fundamental role in neuronal plasticity in the short term (1) . In particular, BDNF is essential to neuronal transmissions and activity-dependent neuronal plasticity (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . Application of BDNF to cultured hippocampal neurons induced an excitatory synaptic transmission (12) , cation influx (13) , generation of action potential (14) , and Ca 2ϩ mobilization (15) . Ca 2ϩ appears to affect processes that are central to the development and plasticity of the CNS (16) , and several patterns of Ca 2ϩ dynamics are known. Spontaneous oscillations in the intracellular Ca 2ϩ concentration occur in developing CNS neurons, and their mechanisms are highly distinct. For example, the activation of nicotinic acetylcholine receptors is involved in the oscillatory activity of the retina, whereas a depolarization through the GABA A receptors is required for hippocampal oscillatory activity. Retinal oscillations are spatially restricted to the domains of amacrine and ganglion cells (17, 18) . By contrast, hippocampal activity consists of transient bursts in the intracellular Ca 2ϩ recurring synchronously over the entire population of pyramidal and interneurons (19) . In the cerebral cortex, several patterns of Ca 2ϩ activity have been observed during cortical development, and the metabotropic glutamate receptors (mGluR), GABA A receptors, gap junctions, and ionotropic glutamate receptors are all able to mediate them. The Ca 2ϩ oscillations mediated by mGluR are triggered by mGluR agonists in neonatal or embryonic cortical mouse slices, and this Ca 2ϩ activity is not synchronized in any population of cells (20) . In the early postnatal stage, GABA A receptor activation has been shown to be involved in Ca 2ϩ oscillations, and again this Ca 2ϩ activity is not synchronized (21) . Gap junction-mediated propagation of Ca 2ϩ waves is not required for synaptic transmission (22) , but an IP 3 -related second messenger system acting via gap junctions is required for synaptic transmission (23) . Recently, the large neuronal networks in slices of newborn rats revealed synchronized Ca 2ϩ oscillations. These Ca 2ϩ activities are mediated by AMPA and NMDA glutamate receptors and are maintained until the developmental transition of the GABAergic transmission from depolarization to hyperpolarization (24) . On the other hand, very little is known about neurotrophin-dependent oscillatory activities in CNS neurons. A previous report has shown that BDNF potentiates the frequency of spontaneous Ca 2ϩ oscillations in cultured hippocampal neurons (25) . However, the mechanism by which BDNF potentiates the oscillatory activity remains unclear.
In the present study, we identified how BDNF potentiates synchronized spontaneous Ca 2ϩ oscillations in cultured cerebral cortical neurons. We present the hypothesis that the BDNF potentiation of Ca 2ϩ oscillations is mediated by glutamate, which is released in response to BDNF via a glutamate transporter. We propose that our system may be a useful tool for understanding how neurotrophins mediate the spontaneous synaptic transmission.
EXPERIMENTAL PROCEDURES
Cell Culture-Primary dissociated cultures were prepared from postnatal 2-or 3-day-old rat (SLC, Sizuoka, Japan) cortex as reported previously (26, 27) . Briefly, cells were gently dissociated with a plastic pipette after digestion with papain (90 units/ml, Worthington) at 37°C. The dissociated cells were plated at a final density of 4 or 5 ϫ 10 5 /cm 2 on polyethyleneimine-coated 12-and 24-well plates (4-and 2-cm 2 surface area/wells, respectively; Corning). The culture medium consisted of 5% precolostrum newborn calf serum, 5% heat-inactivated horse serum, 1% rat serum, 89% of a 1:1 mixture of Dulbecco's modified Eagle's medium, and Ham's F-12 medium containing 15 mM HEPES buffer (pH 7.4), 30 nM Na 2 SeO 3 , and 1.9 mg/ml NaHCO 3 .
Immunocytochemistry-Cells were stained with the anti-MAP2 (rabbit IgG, gift from Dr. H. Murofushi, University of Tokyo), anti-GLU (mouse monoclonal IgG, Sigma), and anti-glutaminase (mouse monoclonal IgM, a gift from Dr. T. Kaneko, Kyoto University) antibodies. Briefly, cells were fixed in 4% paraformaldehyde containing 0.05% Triton X at room temperature for 20 min and then incubated overnight with anti-MAP2 (1:5000) or anti-GLU (1:1000) antibodies diluted with a 0.01% Triton X solution at 4°C. Secondary antibodies were applied at room temperature for 1 h. We used fluorescein isothiocyanate (Seikagaku Kogyo) or rhodamine (Vector Laboratories) secondary antibodies at a dilution of 1:200. For staining with the anti-glutaminase antibody, cells were fixed in 4% paraformaldehyde at room temperature for 20 min and then incubated with the anti-glutaminase antibody diluted 1:250 in a 0.3% Triton X solution. Anti-mouse IgM was used as a second antibody. For visualizing, we used a Vectastain ABC kit (Vector Laboratories) together with 0.02% (w/v) 3,3Ј-diaminobenzidine 4-HCl (DAB) and 0.1% (w/v) (NH 4 )Ni(SO 4 ) 2 dissolved in 0.05 M Tris-HCl buffer (pH 7.6), containing 0.01% (v/v) H 2 O 2 . Immunoreaction was observed with a Nikon DIAPHOT-TMD microscope.
Detection of Amino Acid Neurotransmitters-The amounts of amino acids released from the cultured cortical neurons were measured as described previously (27) . Briefly, the amounts released into the assay buffer (modified HEPES-buffered Krebs Ringer solution: KRH containing 130 mM NaCl, 5 mM KCl, 1.2 mM NaH 2 PO 4 , 1.8 mM CaCl 2 , 10 mM glucose, 1% bovine serum albumin, and 25 mM HEPES (pH 7.4)) were measured by HPLC (BAS) with a fluorescence detector (CMA280, BAS). The high K ϩ (HK ϩ ) solution consisted of 85 mM NaCl, 50 mM KCl, 1.2 mM NaH 2 PO 4 , 1.8 mM CaCl 2 , 10 mM glucose, 1% bovine serum albumin, and 25 mM HEPES (pH 7.4). The Ca 2ϩ -free solution was prepared by omitting the CaCl 2 . Na ϩ -free solution was prepared by the addition of sucrose or LiCl instead of NaCl. Fractions were collected at 1-min intervals in tubes and placed on ice by the batch method and then filtered with 0.22-m membranes to remove cell debris. Next, the samples were treated with O-phthalaldehyde and 2-mercaptoethanol for 5 min at 12°C before being injected into the HPLC system and analyzed using a fluorescence monitor (excitation wavelength, 340 nm; emission wavelength, 445 nm). Xestospongin C (Calbiochem) an IP 3 calcium channel receptor antagonist, was applied at 1 M for 1 h before the assay. U-73122, a PLC-␥ inhibitor, was applied for 1 h at 2 M (28). LY294002 (Calbiochem), a PI3 kinase inhibitor, and PD98059 (Calbiochem), a MAP kinase inhibitor, were applied for 30 min at 50 and 10 M, respectively (29, 30) . L-trans-2, 4-PDC (t-PDC) (Research Biochemicals) was applied for 20 min before the assay at 10 M, while DL-threo-␤-benzyloxyaspartate (DL-TBOA) (a gift from Suntory Institute for Bioorganic Research, Osaka) was applied at 10 M and tetrodotoxin (TTX) (Latoxan) at 0.5 M. When the effects of the various drugs on BDNFinduced glutamate release were examined, the neurons were washed three times, and samples of the basal and BDNF-induced release in the presence of these drugs were collected. BDNF, NT-3, NT-4/5, and NGF were applied by bath application.
Imaging of Intracellular Ca 2ϩ -Cells were cultured on polyethyleneimine-coated cover glasses (Matsunami, Osaka, Japan) attached to flexiperm (IN VITRO, Kalkberg, Osterode). Cells were washed three times with KRH and incubated for 1 h at 37°C with 10 M Fluo-3 AM diluted in KRH. The cells were then washed, and the cover glasses placed on an inverted microscope (TMD-300, Nikon). The dye intensity was monitored using a confocal laser microscope (RCM 8000, Nikon). Neurons were irradiated with an excitation blue light beam (488 nm) produced by an argon ion laser at a scanning frequency of one-thirtieth of a second. The emitted fluorescence was guided through a ϫ40 waterimmersion objective to a pinhole diaphragm at 520 nm using a diachronic mirror. The intensity of emission from each neuron targeted was scanned at one-thirtieth of a second intervals with a monitor video enhancer. BAPTA-AM (100 nM) (Research Biochemicals) and thapsigargin (1 M) (Research Biochemicals) were added 30 min prior to the application of BDNF. Xestospongin C (1 M) and U-73122 (2 M) were added 30 min prior to the imaging assay. DL-TBOA and t-PDC were applied 20 min before the assay at 10 M respectively.
Immunoblotting-Cells were lysed in SDS lysis buffer containing 1% SDS, 20 mM Tris-HCl (pH 7.4), 5 mM EDTA (pH 8.0), 10 mM NaF, 2 mM Na 3 VO 4 , 0.5 mM phenylarsine oxide, and 1 mM phenylmethylsulfonyl fluoride. The lysates were boiled for 3 min, and then clarified by ultracentrifugation at 60,000 ϫ g for 30 min at 8°C. The protein concentration of the supernatants was determined using a BCA protein assay kit (Pierce), and then 10-g aliquots of protein were resolved by electrophoresis on 10% SDS-polyacrylamide gels. Proteins were transferred onto polyvinylidene fluoride membranes (Millipore) in 0.1 M Tris base, 0.192 M glycine, and 20% methanol using a semi-dry electrophoretic transfer system. The membranes were blocked with 0.1% Tween 20/ Tris-buffered saline (T-TBS) containing 5% nonfat dried milk at room temperature for 1 h. Membranes were then probed with 1:500 dilution of anti-phospho-Trk antibody, 1:1000 of anti-Trk antibody, 1:1000 anti-PLC-␥ antibody or 1:1500 of anti-phospho-Tyr antibody in T-TBS containing 1% nonfat dried milk at room temperature for 1 h. After three washes with T-TBS, the membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG or donkey anti-mouse IgG secondary antibody (Zymed Laboratories Inc. or Jackson ImmunoResearch Laboratories) and diluted 1:1000 with T-TBS at room temperature for 1 h. They were then washed at least four times with T-TBS and visualized using the ECL chemiluminescence system (Amersham Biosciences or Immunostar, Wako). The cell lysates for immunoprecipitation assay were prepared using Triton lysis buffer containing 1% Triton X-100, 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA (pH 8.0), 10 mM NaF, 2 mM Na 3 VO 4 , 0.5 mM phenylarsine oxide, and 1 mM phenylmethylsulfonyl fluoride. Subsequently, 250-g aliquots of protein were mixed with 1 g of anti-PLC-␥ antibody and the samples incubated at 4°C for at least 3 h. Protein G-Sepharose (10 l of gel) was then added and the mixtures rotated at 4°C for 1 h. The immune complexes were pelleted by centrifugation at 10,000 ϫ g and 4°C for 1 min before being washed three times with the Triton buffer. After SDS-PAGE, the proteins were immunoblotted with anti-phospho-Tyr antibody. The antiphospho-Trk antibody (31) was purchased from New England Biolabs, whereas the anti-phospho-Tyr and anti-p85 antibodies were from Upstate Biotechnology. The anti-PLC-␥, anti-Trk (32), and anti-MAPK antibodies were from Santa Cruz Biotechnology.
RESULTS

Glutamate-mediated Spontaneous Ca
2ϩ Oscillations in Cultured Cortical Neurons-During the development of cultured neurons obtained from neonatal rat cerebral cortex, networks among neurons were formed, and after this synchronized spontaneous Ca 2ϩ oscillatory activity appeared in the cultured cortical neurons. The synchronous Ca 2ϩ oscillations in developing neurons seemed to indicate the formation of chemical synapses.
To investigate the acute effect of BDNF on spontaneous neuronal activities in cultured CNS neurons, we focused on the BDNF-induced elevation in the frequency of synchronized spontaneous Ca 2ϩ oscillations in cultured cortical neurons. First, we characterized the cortical spontaneous Ca 2ϩ oscillations. The changes of spontaneous Ca 2ϩ oscillations in the cultured cells during neuronal development are shown (Fig. 1,  A and B) . Fig. 1 , A and B, respectively, gives the results from two independent series of developmental experiments. The synchronous spontaneous Ca 2ϩ oscillations begun at around DIV 5 in cultured neurons prepared from P2-3-day-old rats ( Fig. 1, A and B ). At DIV 6 or DIV 7, the frequencies of the Ca 2ϩ oscillations were greater than in cultured neurons at DIV 5. The synchronous Ca 2ϩ oscillations were observed in both neurites and soma, and the time-dependence of the oscillations in the cell bodies was similar to that in neurites (Fig. 1, C and D) . Although some cells in culture did not show oscillatory activities (Fig. 1D, c4) , in this study, we focused on the synchronous spontaneous Ca 2ϩ oscillatory activity. The quantitative data of intracellular Ca 2ϩ were obtained from the analysis of each cell body targeted, because we could detect a much higher intensity of Ca 2ϩ dye emission in cell bodies than in neurites. The cells that showed synchronized activity were clearly defined. To identify which cell population displays the activity, we performed an immunocytochemical staining study using anti-GLU, anti-glutaminase (a marker for glutamatergic neurons) and anti-MAP2 (a marker for neurons) antibodies after the Ca 2ϩ imaging experiment. We confirmed that the cells in synchronized Ca 2ϩ oscillations ( Fig. 2A , a and b) were MAP2 positive ( Fig. 2A, c) , indicating that they were neurons. Almost all of the neurons showing oscillations could be labeled with anti-GLU ( Fig. 2A, d) . Further, we confirmed that cortical neurons displaying oscillations ( Fig. 2A , e and f) express glutaminase and this immunoreactivity was observed in the axons of neurons ( Fig. 2A, g ), indicating that they were glutamatergic neurons (33 oscillations occurred in cells prepared from postnatal 2-3-day-old rat after they had been cultured for 5 days in vitro (DIV 5). Traces indicate three synchronized cells that were selected at random. Imaging of intracellular Ca 2ϩ was performed with the Ca 2ϩ indicator, Fluo-3AM (10 M), and confocal laser microscopy as described under "Experimental Procedures." The changes in intracellular Ca 2ϩ were quantified by normalizing the fluorescence intensity detected to the initial fluorescence intensity (F/F 0 ). B, plots summarize data for the frequency of cortical Ca 2ϩ oscillations occurring during development. The data were determined from a series of experiments distinct from those in Fig. 1A (n ϭ 4, four selected areas from sister cultures). C, a, b, and c images of Fluo-3-filled cells acquired every 4 s at DIV 6. Bar ϭ 50 m. D, the synchronous Ca 2ϩ oscillations were observed in both neurites and soma. The monochrome shows the same area as Fig. 1C . Traces indicate oscillations in cell bodies (c1, c2, and c3) and in neurites (n1 and n2). *, synchronized Ca 2ϩ peaks; c4, resting cell in culture. Bar ϭ 50 m.
voltage-dependent Ca 2ϩ channel blocker, reduced the Ca 2ϩ oscillations (Fig. 2B, a) . APV (a NMDA receptor inhibitor, 10 M) and CNQX (an AMPA receptor inhibitor, 10 M) also blocked the Ca 2ϩ oscillations (Fig. 2B, b) . In an extracellular Ca 2ϩ -free condition, no spontaneous Ca 2ϩ oscillations were observed (Fig. 2B, c) . TTX (a Na ϩ channel blocker) also abolished the oscillations (Fig. 2B, d) . In contrast, the GABA receptor antagonists, bicuculline (10 M) and/or saclofen (10 M) did not block the spontaneous Ca 2ϩ activity. The frequency of oscillations at DIV 6 in the presence of both bicuculline and saclofen was 109 Ϯ 13.1% of nontreated basal activity. These results suggested that voltage-dependent Ca 2ϩ channels and ionotropic glutamate receptors were involved in the synchronous spontaneous Ca 2ϩ oscillations of cultured cortical neurons.
BDNF Potentiated the Synchronous Ca 2ϩ Oscillations in Cultured Cortical
Neurons-To test the possibility that BDNF enhanced the synaptic connectivity, we examined the acute action of BDNF on the spontaneous Ca 2ϩ activity. Application of BDNF potentiated the frequency of the synchronous Ca 2ϩ oscillations at DIV 6 (Fig. 3A, top) . Although in some cases, we observed a resting cortical culture at around DIV 5 or later, BDNF was still capable of triggering continuous Ca 2ϩ oscillations in the resting neurons (data not shown). In contrast, at DIV 3 BDNF induced a transient increase in intracellular Ca 2ϩ , but it did not initiate continuous Ca 2ϩ oscillations (Fig.  3A, bottom) , indicating that the BDNF-potentiated Ca 2ϩ oscillations in cultured cortical neurons required in vitro maturation. The BDNF-potentiated Ca 2ϩ oscillations were sustained for 15-20 min (Fig. 3B) . In some cases, the oscillatory activity was sustained for longer (40 min). NT-3 and NT-4/5 also potentiated the activity, but NGF did not (Fig. 3C ). BDNF and NT-4/5 enhanced the oscillatory activity by the same amount degree. The effect of NT-3 was less than that of BDNF. In the presence of K252a, BDNF did not potentiate the Ca 2ϩ oscillations, although K252a alone did not influence the basal activity (Fig. 3C) . Cortical neurons are known to express TrkB and TrkC but not TrkA receptors. As expected, BDNF, NT-3, and NT-4/5 significantly induced tyrosine phosphorylation of Trk receptors (Fig. 3D ), but NGF did not. These results strongly suggested that the neurotrophin-potentiated Ca 2ϩ oscillations required the Trk activation.
BDNF Triggered Glutamate Release from Cultured Cortical Neurons-It was revealed that the cortical spontaneous Ca 2ϩ oscillations were mediated by glutamate. Previously, we showed that BDNF triggered a rapid glutamate release from the neurons. To test for a correlation between the two phenomena, we examined the BDNF-induced glutamate release during neuronal development (Fig. 4A) . BDNF did not induce glutamate release in early cultured cortical neurons (at DIV 3 and 4). On the other hand, after 5 days in vitro culture or more (DIV 6 -9), BDNF induced significant glutamate release within 1 min after exogenous application. These results indicated that the two phenomena, the BDNF-potentiated Ca 2ϩ oscillations (Fig. 4B, c) . Glutamate (1 M) also triggered transient Ca 2ϩ increases without any frequency potentiation (Fig.  4B, b) . However, in the presence of glutamate (1 M) and 5 ng/ml BDNF, the oscillatory activity was potentiated to the same level as that induced by BDNF alone at 100 ng/ml (Fig.  4B, d and e) . In contrast, the oscillations induced by co-application of glutamate (1 M) with BDNF at 100 ng/ml did not result in any further potentiation over that produced by 100 ng/ml of BDNF alone (Fig. 4C) . These results suggested that the BDNF-potentiated spontaneous Ca 2ϩ oscillations were indeed because of the BDNF-induced glutamate release. Application of glutamate at higher concentrations (50 or 100 M) induced a burst of intracellular Ca 2ϩ increases and resulted in termination of the spontaneous oscillations (data not shown). Thus, we compared the sensitivities to BDNF (5 or 100 ng/ml) with or without glutamate (1 M).
We previously reported that the BDNF-induced glutamate release from cultured cortical neurons was dependent on intracellular Ca 2ϩ (34) and that the PLC-␥/IP 3 pathway was essential for the glutamate release in cultured cerebellar neurons (35) . As shown in Table I (n ϭ 4; four selected areas from sister cultures at DIV 6). **, p Ͻ 0.01 versus none (Student's t test). C, NT-3, and NT-4/5 also potentiated the oscillatory activity, but NGF had no effect (at DIV 6). Neurotrophins were applied to the cultured neurons at 100 ng/ml (n ϭ 4). In the presence of K252a (a Trk kinase inhibitor, 200 nM), BDNF did not potentiate the oscillations. D, BDNF, NT-3, and NT-4/5 (100 ng/ml, respectively) induced significant tyrosine phosphorylation of Trk receptors (at DIV6). NGF (100 ng/ml) did not induce the phosphorylation. Cells, before and after a 10-min treatment of neurotrophins, were collected and the lysates prepared using SDS lysis buffer. The lysates were immunoblotted with anti-phospho-Trk (top) or anti-Trk (bottom) antibodies.
depletion of the intracellular Ca 2ϩ pools) completely abolished the BDNF-induced release. Furthermore, we examined the PLC-␥/IP 3 pathway contribution to the BDNF-induced release. Xestospongin C, a cell-permeable IP 3 receptor antagonist, completely blocked the BDNF-induced release. U-73122, an inhibitor of PLC-␥, also blocked the release. On the other hand, PD98059, a MAP kinase inhibitor, and LY294002, a PI3 kinase inhibitor, had no effect (data not shown). These results suggested that the PLC-␥/IP 3 /Ca 2ϩ pathway is essential for the BDNF-induced glutamate release from cultured cortical neurons as previously shown in cultured cerebellar neurons (35) .
PLC-␥/IP 3 Pathway Is Essential for the BDNF-induced Potentiation of Ca
2ϩ Oscillations-To elucidate the role of TrkB and PLC-␥ in the BDNF-mediated Ca 2ϩ oscillatory activity and glutamate release, we examined the changes in the expression of Trks and PLC-␥ in cultured cortical neurons during maturation in vitro from DIV 3 to DIV 11 (Fig. 5A) . The expression of both molecules increased significantly from DIV 4 and DIV 5 and were maintained until DIV 11. Their expression patterns resembled the spontaneous cortical Ca 2ϩ oscillations, BDNFpotentiated Ca 2ϩ oscillations and BDNF-induced glutamate release. In contrast, the expression of PI3 kinase (p85) and 's t test) . B, effect of BDNF and glutamate co-application on the cortical oscillations. a, none; b, glutamate (1 M) triggered transient Ca 2ϩ increases without any potentiation; c, BDNF (5 ng/ml) alone; d, BDNF (100 ng/ ml) alone; e, co-application of glutamate (1 M) and BDNF (5 ng/ml) potentiated the oscillatory activity. Traces indicate three synchronized cells, which were selected at random. C, plots summarize data from B. The data were determined from six selected areas from sister cultures at DIV 5. The potentiation induced by co-application of BDNF at 5 ng/ml and glutamate (1 M) was the same as with BDNF at 100 ng/ml alone.
TABLE I BDNF induces glutamate release in an intracellular Ca 2ϩ -dependent manner
Cultured cortical neurons (at DIV 6) were treated with BDNF for 1 min by bath application at a concentration of 100 ng/ml. Basal release was measured by collecting for 1 min before the application. BAPTA-AM (100 nM) and thapsigargin (1 M) were added 30 min prior to BDNF, while U-73122 (2 M) and xestospongin C (1 M) were applied to the cultured neurons for 1 h before the assay. Amino acid release assays were performed as described in "Experimental Procedures." Data represent means Ϯ S.D. (n ϭ 4). **, p Ͻ 0.01 vs. basal (Student's t test). 
Potentiation of Ca 2ϩ Oscillation by BDNF
MAP kinase was slightly increased from DIV 3 to DIV 11, but no marked up-regulation was observed. The time-course analysis of PLC-␥ activation after exogenous BDNF application was performed using DIV 6 neurons (Fig. 5B) . Trks and PLC-␥ were activated within 1 min of the BDNF application, and the levels were sustained for at least 60 min. Next, we examined the role of the PLC-␥/IP 3 pathway in the BDNF-potentiated oscillatory Ca 2ϩ activity (Fig. 5C ). Neither xestospongin C nor U-73122 had any effect on the basal oscillations. However, both xestospongin C and U-73122 completely blocked the BDNF-potentiated oscillations, suggesting that the PLC-␥/IP 3 Oscillatory Activity-We previously suggested that reverse transport of glutamate via a glutamate transporter was involved in the BDNF-induced glutamate release rather that exocytosis in cultured cerebellar neurons (35) . Therefore, in the present study we examined the possibility that the reverse uptake of glutamate via the glutamate transporter is involved in the BDNF-potentiated cortical Ca 2ϩ oscillations.
Glutamate and 3Na ϩ are co-transported through the glutamate transporter (36) . Thus, first we confirmed that the BDNFinduced glutamate release in cultured cortical neurons occurred through reverse glutamate transport in a Na ϩ -dependent manner (Table II) . The BDNF-induced release was blocked by treatment with TTX or Na ϩ -free solution. The glutamate transporter inhibitors, t-PDC, and DL-TBOA also blocked the BDNF-induced release. Next, we examined the effects of the transporter inhibitors on the BDNF-potentiated Ca 2ϩ oscillatory activity. Pretreatment with DL-TBOA (10 M) was found to block the BDNF-potentiated Ca 2ϩ oscillations (Fig. 6, A and B) . In addition, another glutamate transporter inhibitor, t-PDC (10 M) also blocked the Ca 2ϩ oscillations (Fig.  6B) , indicating that the BDNF-potentiated Ca 2ϩ oscillations did not appear under conditions in which the reverse transport of glutamate was blocked. Basal Ca 2ϩ oscillatory activity was not influenced by t-PDC and DL-TBOA (10 M, respectively). These results suggested that the release of glutamate via the transporters was involved in the BDNF-potentiated Ca 2ϩ oscillations.
DISCUSSION
The results of the present study allow us to draw the following conclusions. 1) Synchronized spontaneous Ca 2ϩ oscillations occurred even in immature cultured cortical neurons. However, no oscillatory activity was observed soon after the culture, but started from DIV 5, and the frequency of oscillations reached a peak at approximately DIV 6 -7 in cells dissociated from postnatal2-3-day-oldrats.TheCa 2ϩ oscillationsoccurredviavoltagedependent Ca 2ϩ channels and ionotropic glutamate receptors. 2) BDNF potentiated the synchronized spontaneous Ca 2ϩ oscillations. The BDNF-potentiated oscillations was mediated by BDNF-induced glutamate release which occurred through a PLC-␥/IP 3 -dependent pathway.
3) The reverse transport of glutamate via glutamate transporter may be involved in the Ca 2ϩ oscillations potentiated by BDNF.
Spontaneous oscillatory activity patterns are believed to promote the establishment of region-specific connections. In the cortex, it was reported that spontaneous oscillations were seen only in individual cells (20, 21) from small groups consisting of 5-50 neurons (37) or in larger populations (24) . The spontaneous cortical activities are assumed to differ. They are mediated by activation of metabotropic glutamate (20) or GABA A (21) receptors or by Ca 2ϩ mediated by IP 3 through gap junctions (23) . In this study, we found that synchronized spontaneous Ca 2ϩ oscillations occurred in cortical neurons obtained from postnatal 2-3-day-old rats after 5 days of in vitro culture (DIV 5). At DIV 6 or DIV 7, the frequencies of Ca 2ϩ oscillations were FIG. 5 . PLC-␥/IP 3 pathway is essential for the potentiation of Ca 2؉ oscillations induced by BDNF. A, the changes in the expression of Trk, PLC-␥, p85, or MAPK in cultured cortical neurons during developmental maturation ranging from DIV 3 to DIV 11. The cells were lysed with SDS lysis buffer on the indicated days. The expression of both Trk and PLC-␥ increased at around DIV 5. The protein level of PLC-␥, Trk, p85, and MAPK was detected by Western blot analysis. B, time-course analysis of PLC-␥ activation after BDNF was applied at DIV 6. The cell lysates were prepared 0, 1, 3, 5, 10, 30, and 60 min after BDNF treatment using Triton lysis buffer. The lysates were immunoprecipitated with 1 g of anti-PLC-␥ antibody. After SDS-PAGE, the immunoprecipitants were blotted with anti-phospho-Tyr antibody (top). The same lysates were immunoblotted with anti-PLC-␥ antibody (bottom). PLC-␥ was activated within 1 min after the BDNF (100 ng/ml) application and was sustained for at least 60 min. C, the PLC-␥/IP 3 pathway was involved in BDNF-potentiated Ca 2ϩ oscillations. The changes in the frequency of Ca 2ϩ oscillatory activity were detected for 100 s after application of BDNF. Basal activity was determined for 100 s before the application. Xestospongin C (1 M) and U-73122 (2 M) completely blocked the BDNF-potentiated oscillatory activity. Data represent means Ϯ S.D. (n ϭ 6, six selected areas from sister cultures at DIV 6); **, p Ͻ 0.01 versus basal activity (Student's t test).
much increased compared with those of cultured neurons at DIV 5. The maximum frequency of oscillatory activity was 5-7 times/min. Garaschuk et al. (24) have reported on large scale oscillatory activities in immature cortical slices that require activation of AMPA and NMDA receptors and are associated with changes in membrane potential. They have indicated that the Ca 2ϩ oscillations are maintained at least until P5 after birth, and the oscillatory frequency is 1 wave per 20 -50 min. Thus, the characteristics of the large scale oscillatory activity were different from those of the oscillatory activity seen in our system, indicating that there is a distinct mechanism behind the fast oscillatory activity that we observed. In some cases we observed a resting culture at DIV 5 or later. Thus, we examined stimulation-evoked transient Ca 2ϩ increases (amplitude) using both the oscillatory and the resting cultures. Both showed similar levels of response to HK ϩ (50 mM), glutamate (10 M), and NMDA (10 M) (data not shown), suggesting that the sensitivities of the ionotropic glutamate receptors were the same between the oscillatory and the resting cultures. We found that BDNF triggered continuous synchronized Ca 2ϩ oscillations in the resting culture (data not shown), implying that the cortical synapses were developed. However, in the present study, to clarify the effects of BDNF on the spontaneous synaptic transmission, we used cultured neurons that displayed synchronous spontaneous oscillations.
BDNF is believed to exert an essential role on neuronal transmission and activity-dependent neuronal plasticity after synaptic maturation. However, the developmental change in the acute action of BDNF on spontaneous synaptic transmission in developing CNS neurons has not been clear. Here, we showed that BDNF potentiated the synchronous Ca 2ϩ oscillations in cultured cortical neurons. We also found that the BDNF-induced glutamate release was observed from around DIV 5, consistent with the initiation of the BDNF-potentiated oscillations during the neuronal development. These results suggested that the BDNF-induced glutamate release was essential for the potentiation of Ca 2ϩ oscillations. In addition, we examined a dose-dependent effect of BDNF on the glutamate release (data not shown). An increase in the glutamate release began to be observed at 5 ng/ml BDNF, and it reached a plateau at 100 ng/ml. On the other hand, the potentiation of the Ca 2ϩ oscillations was not observed at 5 ng/ml BDNF (Fig. 4) . These results indicate that the glutamate release stimulated by 5 ng/ml BDNF is not sufficient for the potentiation of Ca 2ϩ oscillations. However, co-application of BDNF and glutamate (5 ng/ml and 1 M, respectively) significantly stimulated the potentiation of Ca 2ϩ oscillations, suggesting that the extracellular concentration of glutamate was important.
In view of GABA's widespread excitatory action in the immature cortical (38) and hippocampal neurons (19, 39, 40) , we determined the percentage of cells showing GABA-activated Ca 2ϩ influx at DIV 3 and DIV 6. At DIV 3, 88% of cells showed GABA-activated Ca 2ϩ . In contrast, at DIV 6, only 14% of cells showed GABA-activated Ca 2ϩ , whereas 81% of cells showed glutamate-activated Ca 2ϩ . We also confirmed that neither bicuculline nor saclofen could block the spontaneous Ca 2ϩ activity and that the cultured cortical neurons showing spontaneous Ca 2ϩ oscillations were glutamatergic neurons. Therefore, BDNF exerted its potentiation of the Ca 2ϩ oscillations through glutamate after terminating GABA's depolarizing action in developing cortical neurons.
We found that the BDNF-induced glutamate release occurred through the PLC-␥ pathway that stimulates an IP 3 -mediated increase in the intracellular Ca 2ϩ level of cortical neurons. The BDNF-induced release was not observed until the neurons had been maintained in culture for 5 days or longer. Thus, we investigated the changes in expression of PLC-␥. The PLC-␥ expression was remarkably up-regulated at DIV 5 and sustained in neurons cultured longer (until DIV 11). In contrast, no marked up-regulation of PI3 kinase (p85) or MAP kinase was observed at DIV 5. The initiation of the PLC-␥ expression up-regulation was consistent with that of the BDNF-induced glutamate release. BDNF induced transient receptor. TRPC3 protein is expressed in CNS neurons during a narrow developmental window before and after birth. In the present study, the BDNF-potentiated Ca 2ϩ oscillations seemed to be correlated with synaptic maturation in developing cortical neurons. The response to BDNF began to be observed more than 5 days after the culture (from postnatal 2-3-day-old rats) and increased during in vitro maturation. Therefore, TRPC3 is not thought to be involved in the BDNF-induced glutamate release and potentiation of Ca 2ϩ oscillations in the cultured cortical neurons. Regarding the rapidity of BDNF action, Li et al. (13) have reported that a delay (1.2 Ϯ 0.6 min) is observed in the BDNF-activated currents through TRPC channels. The present study showed that both the BDNF-potentiated Ca 2ϩ oscillations and the BDNF-induced glutamate release were triggered within 1 min. Interestingly, a recent electrophysiological study has shown that BDNF elicited action potentials within a few milliseconds in hippocampal, cortical pyramidal, cerebellum granule, and Purkinje cells (14) . In this case, the signal transduction through the activation of TrkB tyrosine kinase seems to be excluded judging from the rapidity of onset of the BDNF-induced depolarization in the low millisecond range. These studies suggest that BDNF regulates synaptic action in the CNS through a variety of mechanisms. Kafitz et al. (14) identified a TTX-insensitive Na ϩ -permeable channel as mediating the acute response to BDNF. In contrast, the BDNF-induced glutamate release was extracellular Na ϩ -dependent and TTX-sensitive. In addition, glutamate transporter inhibitors completely blocked the BDNF-induced release, suggesting that the Na ϩ -dependent reverse transport of glutamate was involved in this process, as was found with cultured cerebellar neurons (35) . Using the specific inhibitors of glutamate transporters mentioned above, we examined the possibility that the reverse transport of glutamate was involved in the BDNF-potentiated Ca 2ϩ oscillations. Pretreatment with transporter inhibitors completely blocked the potentiated activity, suggesting that the acute effect of BDNF on Ca 2ϩ oscillations was mediated by glutamate via the transporter.
This raises the question of whether the basal spontaneous oscillatory activities in developing cortical neurons are mediated through conventional synapses or whether there is spillover of glutamate via synapses or/and nonexocytotic release, as suggested for some transmitters (42) (43) (44) . It has been reported that depolarization-evoked glutamate release from hippocampal slices in neonates occurred via reverse transport rather than via exocytosis as in adults (45) . In our system, TBOA (50 -100 M) attenuated the frequency of basal oscillations (data not shown). Several types of glutamate transporters are known to be expressed in glial cells and neurons (46 -48) . L-glutamate/L-aspartate transporter (GLAST) and GLT-1 are expressed in glial cells, and the neuronal glutamate transporter, EAAC1, is expressed in cortex (49). Shimamoto et al. (50) have reported that TBOA has an IC 50 of 67 Ϯ 7.5 M for GLT-1 and 5.5 Ϯ 1.0 M for GLAST. TBOA (50 -100 M) seems to be sufficient to block EAAC1 activity. Therefore, in addition to exocytosis, reverse transport of glutamate may be involved in the basal spontaneous oscillatory action in developing cortical neurons, and BDNF may promote glutamate release via the transporter system. At a more mature stage, BDNF may induce glutamate release via exocytosis. However, our results suggested that reverse transport was essential for the BDNFmodulated synaptic transmission in immature cortical networks.
The (55, 56) . Neurotrophin expression is also regulated in an activity-dependent manner, and glutamate regulates the expression of neurotrophins (57, 58) . Thus, we proposed that the BDNF-potentiated Ca 2ϩ oscillations could influence many aspects of neuronal growth and differentiation including maturation of glutamatergic synapses through these positive feed-forward loops in the cortical network.
